Related references
Note: Only part of the references are listed.Anti-tumor therapy with macroencapsulated endostatin producer cells
Danielle B. Rodrigues et al.
BMC BIOTECHNOLOGY (2010)
Proteoglycans: from structural compounds to signaling molecules
Liliana Schaefer et al.
CELL AND TISSUE RESEARCH (2010)
Proteoglycans in health and disease: the multiple roles of syndecan shedding
Tina Manon-Jensen et al.
FEBS JOURNAL (2010)
Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans
Renato V. Iozzo et al.
FEBS JOURNAL (2010)
Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis
Uri Barash et al.
FEBS JOURNAL (2010)
The road toward microRNA therapeutics
Anita G. Seto
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Ligation of TLR2 by Versican: A Link Between Inflammation and Metastasis
Wei Wang et al.
ARCHIVES OF MEDICAL RESEARCH (2009)
Role of tyrosine phosphatase SHP-1 in the mechanism of endorepellin angiostatic activity
Alexander Nystroem et al.
BLOOD (2009)
The biological role and regulation of versican levels in cancer
Carmela Ricciardelli et al.
CANCER AND METASTASIS REVIEWS (2009)
Tumor stroma derived biomarkers in cancer
Malin Sund et al.
CANCER AND METASTASIS REVIEWS (2009)
The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells In vitro and In vivo
Hiroshi Ikeda et al.
CLINICAL CANCER RESEARCH (2009)
Targeting Epidermal Growth Factor Receptor in Solid Tumors: Critical Evaluation of the Biological Importance of Therapeutic Monoclonal Antibodies
Ch. Gialeli et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Lumcorin: A leucine-rich repeat 9-derived peptide from human lumican inhibiting melanoma cell migration
Cedric Zeltz et al.
FEBS LETTERS (2009)
Fibroblast growth factor-2 modulates melanoma adhesion and migration through a syndecan-4-dependent mechanism
Georgia Chalkiadaki et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Decorin is a novel antagonistic ligand of the Met receptor
Silvia Goldoni et al.
JOURNAL OF CELL BIOLOGY (2009)
Basement membrane proteoglycans: Modulators Par Excellence of cancer growth and angiogenesis
Renato V. Iozzo et al.
MOLECULES AND CELLS (2009)
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
Sunhwa Kim et al.
NATURE (2009)
A 3′-Untranslated Region (3′UTR) Induces Organ Adhesion by Regulating miR-199a*Functions
Daniel Y. Lee et al.
PLOS ONE (2009)
Heparanase: busy at the cell surface
Liat Fux et al.
TRENDS IN BIOCHEMICAL SCIENCES (2009)
An antimetastatic role for decorin in breast cancer
Silvia Goldoni et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Regulation of hyaluronan and versican deposition by growth factors in fibrosarcoma cell lines
A. Berdiaki et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2008)
MicroRNAs Impair MET-Mediated Invasive Growth
Cristina Migliore et al.
CANCER RESEARCH (2008)
Versican in health and disease
Achilleas D. Theocharis
CONNECTIVE TISSUE RESEARCH (2008)
Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding
Mariana I. Capurro et al.
DEVELOPMENTAL CELL (2008)
Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs
Silvia Goldoni et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
The proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motility
Bin Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Biological functions of the small leucine-rich proteoglycans: From genetics to signal transduction
Liliana Schaefer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Decorin-induced growth inhibition is overcome through protracted expression and activation of epidermal growth factor receptors in osteosarcoma cells
Alexandros Zafiropoulos et al.
MOLECULAR CANCER RESEARCH (2008)
Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation
Angela Kadenhe-Chiweshe et al.
MOLECULAR CANCER RESEARCH (2008)
Metastasis is strongly reduced by the matrix metalloproteinase inhibitor Galardin in the MMTV-PymT transgenic breast cancer model
Kasper Almholt et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Estradiol-estrogen receptor: A key interplay of the expression of syndecan-2 and metalloproteinase-9 in breast cancer cells
Olga Ch. Kousidou et al.
MOLECULAR ONCOLOGY (2008)
Identification of circulating endorepellin LG3 fragment: Potential use as a serological biomarker for breast cancer
Jong Wook Chang et al.
PROTEOMICS CLINICAL APPLICATIONS (2008)
Serglycin - Structure and biology
S. O. Kolset et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Lumican expression is positively correlated with the differentiation and negatively with the growth of human osteosarcoma cells
Dragana Nikitovic et al.
FEBS JOURNAL (2008)
Serglycin proteoglycan in hematologic malignancies: a marker of acute myeloid leukemia
C. U. Niemann et al.
LEUKEMIA (2007)
Comparison of the expression of agrin, a basement membrane heparan sulfate proteogtycan, in cholangiocarcinoma and hepatocellular carcinoma
Enkhjargat Batmunkh et al.
HUMAN PATHOLOGY (2007)
Expression of decorin, a small leucine-rich proteoglycan, as a prognostic factor in soft tissue tumors
Akihiko Matsumine et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
Versican expression in human cervical cancer
J. Kodama et al.
EUROPEAN JOURNAL OF CANCER (2007)
The role of versican isoforms V0/V1 in glioma migration mediated by transforming growth factor-β2
F. Arslan et al.
BRITISH JOURNAL OF CANCER (2007)
The ability of versican to simultaneously cause apoptotic resistance and sensitivity
David P. LaPierre et al.
CANCER RESEARCH (2007)
Formation of hyaluronan- and versican-rich pericellular matrix by prostate cancer cells promotes cell motility
Carmela Ricciardelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma
Matti Pukkila et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Frequent requirement of hedgehog signaling in non-small cell lung carcinoma
Z. Yuan et al.
ONCOGENE (2007)
Prognostic significance of stromal versican expression in human endometrial cancer
J. Kodama et al.
ANNALS OF ONCOLOGY (2007)
The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis
Albert Jm Yee et al.
BREAST CANCER RESEARCH (2007)
The function of a Drosophila glypican does not depend entirely on heparan sulfate modification
Catherine A. Kirkpatrick et al.
DEVELOPMENTAL BIOLOGY (2006)
Versican but not decorin accumulation is related to metastatic potential and neovascularization in testicular germ cell tumours
V. T. Labropoulou et al.
HISTOPATHOLOGY (2006)
Hyaluronan constitutively regulates activation of multiple receptor tyrosine kinases in epithelial and carcinoma cells
Suniti Misra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Serglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitro
Achilleas D. Theocharis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Endorepellin in vivo: Targeting the tumor vasculature and retarding cancer growth and metabolism
Gregory Bix et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Modulation of cell-fibronectin matrix interactions during tissue repair
Kim S. Midwood et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2006)
V3 versican isoform expression has a dual role in human melanoma tumor growth and metastasis
Laia Miquel-Serra et al.
LABORATORY INVESTIGATION (2006)
Expression profiling correlates with treatment response in women with advanced serous epithelial ovarian cancer
Tanya R. Newton et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
The greatly increased amounts of accumulated versican and decorin with specific post-translational modifications may be closely associated with the malignant phenotype of pancreatic cancer
Spyros S. Skandalis et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2006)
Cartilage aggrecan undergoes significant compositional and structural alterations during laryngeal cancer
Spyros S. Skandalis et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2006)
Syndecan-2 is expressed in the microvasculature of gliomas and regulates angiogenic processes in microvascular endothelial cells
Constance Y. Fears et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Syndecan-1 expression by stromal. broblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis
T Maeda et al.
ONCOGENE (2006)
Transforming growth factor-beta as a key molecule triggering the expression of versican isoforms V0 and V1, hyaluronan synthase-2 and synthesis of hyaluronan in malignant osteosarcoma cells
D Nikitovic et al.
IUBMB LIFE (2006)
The role of syndecans in disease and wound healing
Constance Y. Fears et al.
MATRIX BIOLOGY (2006)
Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells
K Ding et al.
JOURNAL OF CELL BIOLOGY (2005)
Constitutive and accelerated shedding of murine syndecan-1 is mediated by cleavage of its core protein at a specific juxtamembrane site
ZH Wang et al.
BIOCHEMISTRY (2005)
Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis
JX Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Novel tumor-specific isoforms of BEHAB/Brevican identified in human malignant gliomas
MS Viapiano et al.
CANCER RESEARCH (2005)
The interaction of versican with its binding partners
YJ Wu et al.
CELL RESEARCH (2005)
V3 versican isoform expression alters the phenotype of melanoma cells and their tumorigenic potential
M Serra et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Loss of cell-surface heparan sulfate expression in both cervical intraepithelial neoplasm and invasive cervical cancer
Y Shinyo et al.
GYNECOLOGIC ONCOLOGY (2005)
BMP-1/tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan
EM Gonzalez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Decorin prevents metastatic spreading of breast cancer
CC Reed et al.
ONCOGENE (2005)
The loss of glypican-3 induces alterations in wnt signaling
HH Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Epithelial syndecan-1 expression is associated with stage and grade in colorectal cancer
M Lundin et al.
ONCOLOGY (2005)
Syndecan-1 expression - A novel prognostic marker in pancreatic cancer
A Juuti et al.
ONCOLOGY (2005)
Versican in nonsmall cell lung cancer: relation to hyaluronan, clinicopathologic factors, and prognosis
R Pirinen et al.
HUMAN PATHOLOGY (2005)
Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer
S Suwiwat et al.
CLINICAL CANCER RESEARCH (2004)
Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma
Y Hippo et al.
CANCER RESEARCH (2004)
Endostatin's antiangiogenic signaling network
A Abdollahi et al.
MOLECULAR CELL (2004)
Heparanase degrades syndecan-1 and perlecan heparan sulfate - Functional implications for tumor cell invasion
J Reiland et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Syndecan-1 expression in locally invasive and metastatic prostate cancer
D Chen et al.
UROLOGY (2004)
Induction of syndecan-1 expression in stromal fibroblasts promotes proliferation of human breast cancer cells
T Maeda et al.
CANCER RESEARCH (2004)
Pancreatic tumor cells influence the composition of the extracellular matrix
J Köninger et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer
M Kubo et al.
CANCER RESEARCH (2004)
Membrane-associated heparan sulfate proteoglycans are involved in the recognition of cellular targets by NKp30 and NKp46
N Bloushtain et al.
JOURNAL OF IMMUNOLOGY (2004)
Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice
ZJ Zhou et al.
CANCER RESEARCH (2004)
Overexpressed decorin in pancreatic cancer:: Potential tumor growth inhibition and attenuation of chemotherapeutic action
J Köninger et al.
CLINICAL CANCER RESEARCH (2004)
Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through α2β1 integrin
G Bix et al.
JOURNAL OF CELL BIOLOGY (2004)
Matrix proteoglycans are markedly affected in advanced laryngeal squamous cell carcinoma
SS Skandalis et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2004)
The small leucine-rich proteoglycan lumican inhibits melanoma progression
B Vuillermoz et al.
EXPERIMENTAL CELL RESEARCH (2004)
Effects of ectopic decorin in modulating intracranial glioma progression in vivo, in a rat syngeneic model
A Biglari et al.
CANCER GENE THERAPY (2004)
Proteoglycans in atherosclerosis and restenosis - Key roles for versican
TN Wight et al.
CIRCULATION RESEARCH (2004)
Identification of glypican-3 as a novel tumor marker for melanoma
T Nakatsura et al.
CLINICAL CANCER RESEARCH (2004)
Cleavage of lumican by membrane-type matrix metalloproteinase-1 abrogates this proteoglycan-mediated suppression of tumor cell colony formation in soft agar
YY Li et al.
CANCER RESEARCH (2004)
Prognostic value of syndecan-1 expression in breast cancer
M Leivonen et al.
ONCOLOGY (2004)
Plasminogen activator inhibitor-1 supports IL-8-mediated neutrophil transendothelial migration by inhibition of the constitutive shedding of endothelial IL-8/heparan sulfate/syndecan-1 complexes
LJ Marshall et al.
JOURNAL OF IMMUNOLOGY (2003)
High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis
M Barbareschi et al.
CANCER (2003)
Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma
P Mukunyadzi et al.
MODERN PATHOLOGY (2003)
Syndecan-1-mediated cell spreading requires signaling by αvβ3 integrins in human breast carcinoma cells
DM Beauvais et al.
EXPERIMENTAL CELL RESEARCH (2003)
Selective inhibition of ADAMTS-1,-4 and -5 by catechin gallate esters
MN Vankemmelbeke et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Altered content composition and structure of glycosaminoglycans and proteoglycans in gastric carcinoma
AD Theocharis et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor
H Kim et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53
H Yoon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Human colon adenocarcinoma is associated with specific post-translational modifications of versican and decorin
AD Theocharis
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
Versican: a versatile extracellular matrix proteoglycan in cell biology
TN Wight
CURRENT OPINION IN CELL BIOLOGY (2002)
Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells
H Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Soluble syndecan-1 promotes growth of myeloma tumors in vivo
Y Yang et al.
BLOOD (2002)
Glypican-3 expression is markedly decreased in human gastric cancer but not in esophageal cancer
ZW Zhu et al.
AMERICAN JOURNAL OF SURGERY (2002)
The role of syndecan-2 in regulation of actin-cytoskeletal organization of Lewis lung carcinoma-derived metastatic clones
S Munesue et al.
BIOCHEMICAL JOURNAL (2002)
Versican is differentially expressed in human melanoma and may play a role in tumor development
M Touab et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas
C Mundhenke et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
High syndecan-1 expression is associated with favourable outcome in squamous cell lung carcinoma treated with radical surgery
A Anttonen et al.
LUNG CANCER (2001)
Oligomerization-dependent regulation of motility and morphogenesis by the collagen XVIII NC1/endostatin domain
CJ Kuo et al.
JOURNAL OF CELL BIOLOGY (2001)
Generation and degradation of human endostatin proteins by various proteinases
M Ferreras et al.
FEBS LETTERS (2000)
An anti-oncogenic role for decorin - Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells
M Santra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Sustained down-regulation of the epidermal growth factor receptor by decorin -: A mechanism for controlling tumor growth in vivo
G Csordás et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice
CM Alexander et al.
NATURE GENETICS (2000)
Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases
BV Sauter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Shedding of syndecan-1 and-4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase
ML Fitzgerald et al.
JOURNAL OF CELL BIOLOGY (2000)
Syndecan-4 binding to the high affinity heparin-binding domain of fibronectin drives focal adhesion formation in fibroblasts
A Woods et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2000)
Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma
SS Murthy et al.
ONCOGENE (2000)
Share Paper
